| Identification | Back Directory | [Name]
LACTO-N-FUCOPENTAOSE I | [CAS]
7578-25-8 | [Synonyms]
LNF-1
LNF I
LNFP I
IV2FUC-LCOSE4
LACTO-N-FUCOPENTAOSE-1
LACTO-N-FUCOPENTAOSE I
Lacto-N-fucopentaose Ⅰ
Lacto-N-fucopentaose I (LNFP I)
Lacto-N-neofucopentaose I (LnNFP-I)
LACTO-N-FUCOPENTAOSE I FROM HUMAN MILK
α-l-fuc (1→2)-β-d-gal-(1→3)-β-d-glcnac-(1→3)-β-d-gal-(1→4)-d-glc
Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I)
LNFP I, α-L-Fuc (1-2)-β-D-Gal-(1-3)-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc
ALPHA-L-FUC [1->2]-BETA-D-GAL-[1->3]-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-D-GLC
alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp
D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-
N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3S,4R,5R)-6-hydroxy-1-oxo-2,4-bis[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexan-3-yl]oxyoxan-3-yl]acetamide
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-4-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide | [Molecular Formula]
C32H55NO25 | [MDL Number]
MFCD00792849 | [MOL File]
7578-25-8.mol | [Molecular Weight]
853.77 |
| Hazard Information | Back Directory | [Chemical Properties]
White solid | [Uses]
LNF-1 human milk saccharide, contains blood group O (H) type I determinant | [Definition]
ChEBI: A linear amino pentasaccharide comprising one fucose, two galactose, one glucosamine and one glucose unit (at the reducing end), linked as shown. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.is0513.com/showsupplierproductslist1701258/0.htm |
|